Multi-drug-resistant Gram-negative bacteria
Hanna E Sidjabat , Witchuda Kamolvit , Alexander Wailan and David L Paterson
+ Author Affiliations
- Author Affiliations
The University of Queensland, UQ Centre for Clinical Research
Royal Brisbane and Women’s Hospital Complex
Brisbane, Qld 4029
AustraliaTel: +61 7 3346 6073
Fax: +61 7 3346 5598
Email: h.sidjabat@uq.edu.au
Microbiology Australia 34(1) 43-46 https://doi.org/10.1071/MA13014
Published: 20 March 2013
Abstract
The increasing prevalence of antibiotic-resistant Gram-negative bacteria is a serious concern not only for humans but also companion animals. Recent clinical attention has focused on the increasing frequency of Gram-negative pathogens responsible for hospital-acquired infections. In this group, extended-spectrum β-lactamase (ESBL) and carbapenemase producing Enterobacteriaceae, in particular E. coli and K. pneumoniae, as well as carbapenemase producing A. baumannii, have caused major challenges in the past decade. These three groups of organisms will be the focus of this article.
References
[1] Sanchez, S. et al. (2002) Characterization of multidrug-resistant Escherichia coli isolates associated with nosocomial infections in dogs. J. Clin. Microbiol. 40, 3586–3595.| Characterization of multidrug-resistant Escherichia coli isolates associated with nosocomial infections in dogs.Crossref | GoogleScholarGoogle Scholar |
[2] Sidjabat, H.E. et al. (2006) Identification of bla CMY-7 and associated plasmid-mediated resistance genes in multidrug-resistant Escherichia coli isolated from dogs at a veterinary teaching hospital in Australia. J. Antimicrob. Chemother. 57, 840–848.
| Identification of bla CMY-7 and associated plasmid-mediated resistance genes in multidrug-resistant Escherichia coli isolated from dogs at a veterinary teaching hospital in Australia.Crossref | GoogleScholarGoogle Scholar |
[3] Sidjabat, H.E. et al. (2006) Emergence and spread of two distinct clonal groups of multidrug-resistant Escherichia coli in a veterinary teaching hospital in Australia. J. Med. Microbiol. 55, 1125–1134.
| Emergence and spread of two distinct clonal groups of multidrug-resistant Escherichia coli in a veterinary teaching hospital in Australia.Crossref | GoogleScholarGoogle Scholar |
[4] Ambler R.P. (1980 )
[5] Mataseje, L.F. et al. (2010) Comparison of CMY-2 plasmids isolated from human, animal, and environmental Escherichia coli and Salmonella spp. from Canada. Diagn. Microbiol. Infect. Dis. 67, 387–391.
| Comparison of CMY-2 plasmids isolated from human, animal, and environmental Escherichia coli and Salmonella spp. from Canada.Crossref | GoogleScholarGoogle Scholar |
[6] Winokur, P.L. et al. (2000) Animal and human multidrug-resistant, cephalosporin-resistant salmonella isolates expressing a plasmid-mediated CMY-2 AmpC beta-lactamase. Antimicrob. Agents Chemother. 44, 2777–2783.
| Animal and human multidrug-resistant, cephalosporin-resistant salmonella isolates expressing a plasmid-mediated CMY-2 AmpC beta-lactamase.Crossref | GoogleScholarGoogle Scholar |
[7] Sidjabat, H.E. et al. (2009) Clinical features and molecular epidemiology of CMY-type beta-lactamase-producing Escherichia coli. Clin. Infect. Dis. 48, 739–744.
| Clinical features and molecular epidemiology of CMY-type beta-lactamase-producing Escherichia coli.Crossref | GoogleScholarGoogle Scholar |
[8] Livermore, D.M. et al. (2007) CTX-M: changing the face of ESBLs in Europe. J. Antimicrob. Chemother. 59, 165–174.
| CTX-M: changing the face of ESBLs in Europe.Crossref | GoogleScholarGoogle Scholar |
[9] O’Keefe, A. et al. (2010) First detection of CTX-M and SHV extended-spectrum beta-lactamases in Escherichia coli urinary tract isolates from dogs and cats in the United States. Antimicrob. Agents Chemother. 54, 3489–3492.
| First detection of CTX-M and SHV extended-spectrum beta-lactamases in Escherichia coli urinary tract isolates from dogs and cats in the United States.Crossref | GoogleScholarGoogle Scholar |
[10] Timofte, D. et al. (2011) Detection of extended-spectrum-beta-lactamase-positive Escherichia coli in bile isolates from two dogs with bacterial cholangiohepatitis. J. Clin. Microbiol. 49, 3411–3414.
| Detection of extended-spectrum-beta-lactamase-positive Escherichia coli in bile isolates from two dogs with bacterial cholangiohepatitis.Crossref | GoogleScholarGoogle Scholar |
[11] Tian, G.B. et al. (2009) Detection of CTX-M-15, CTX-M-22, and SHV-2 extended-spectrum beta-lactamases (ESBLs) in Escherichia coli fecal-sample isolates from pig farms in China. Foodborne Pathog. Dis. 6, 297–304.
| Detection of CTX-M-15, CTX-M-22, and SHV-2 extended-spectrum beta-lactamases (ESBLs) in Escherichia coli fecal-sample isolates from pig farms in China.Crossref | GoogleScholarGoogle Scholar |
[12] Johnson, J.R. et al. (2006) Phylogenetic relationships among clonal groups of extraintestinal pathogenic Escherichia coli as assessed by multi-locus sequence analysis. Microbes Infect. 8, 1702–1713.
| Phylogenetic relationships among clonal groups of extraintestinal pathogenic Escherichia coli as assessed by multi-locus sequence analysis.Crossref | GoogleScholarGoogle Scholar |
[13] Rogers, B.A. et al. (2011) Escherichia coli O25b-ST131: a pandemic, multiresistant, community-associated strain. J. Antimicrob. Chemother. 66, 1–14.
| Escherichia coli O25b-ST131: a pandemic, multiresistant, community-associated strain.Crossref | GoogleScholarGoogle Scholar |
[14] Sidjabat, H.E. et al. (2010) Escherichia coli ST131 producing CTX-M-15 in Australia. J. Antimicrob. Chemother. 65, 1301–1303.
| Escherichia coli ST131 producing CTX-M-15 in Australia.Crossref | GoogleScholarGoogle Scholar |
[15] Ewers, C. et al. (2010) Emergence of human pandemic O25:H4-ST131 CTX-M-15 extended-spectrum-beta-lactamase-producing Escherichia coli among companion animals. J. Antimicrob. Chemother. 65, 651–660.
| Emergence of human pandemic O25:H4-ST131 CTX-M-15 extended-spectrum-beta-lactamase-producing Escherichia coli among companion animals.Crossref | GoogleScholarGoogle Scholar |
[16] Platell, J.L. et al. (2010) Clonal group distribution of fluoroquinolone-resistant Escherichia coli among humans and companion animals in Australia. J. Antimicrob. Chemother. 65, 1936–1938.
| Clonal group distribution of fluoroquinolone-resistant Escherichia coli among humans and companion animals in Australia.Crossref | GoogleScholarGoogle Scholar |
[17] Johnson, J.R. et al. (2009) Sharing of Escherichia coli sequence type ST131 and other multidrug-resistant and urovirulent E. coli strains among dogs and cats within a household. J. Clin. Microbiol. 47, 3721–3725.
| Sharing of Escherichia coli sequence type ST131 and other multidrug-resistant and urovirulent E. coli strains among dogs and cats within a household.Crossref | GoogleScholarGoogle Scholar |
[18] Johnson, J.R. et al. (2009) Virulence genotypes and phylogenetic background of fluoroquinolone-resistant and susceptible Escherichia coli urine isolates from dogs with urinary tract infection. Vet. Microbiol. 136, 108–114.
| Virulence genotypes and phylogenetic background of fluoroquinolone-resistant and susceptible Escherichia coli urine isolates from dogs with urinary tract infection.Crossref | GoogleScholarGoogle Scholar |
[19] Cortes, P. et al. (2010) Isolation and characterization of potentially pathogenic antimicrobial-resistant Escherichia coli strains from chicken and pig farms in Spain. Appl. Environ. Microbiol. 76, 2799–2805.
| Isolation and characterization of potentially pathogenic antimicrobial-resistant Escherichia coli strains from chicken and pig farms in Spain.Crossref | GoogleScholarGoogle Scholar |
[20] Vincent, C. et al. (2010) Food reservoir for Escherichia coli causing urinary tract infections. Emerg. Infect. Dis. 16, 88–95.
| Food reservoir for Escherichia coli causing urinary tract infections.Crossref | GoogleScholarGoogle Scholar |
[21] Nordmann, P. et al. (2011) Global spread of Carbapenemase-producing Enterobacteriaceae. Emerg. Infect. Dis. 17, 1791–1798.
| Global spread of Carbapenemase-producing Enterobacteriaceae.Crossref | GoogleScholarGoogle Scholar |
[22] Cantón, R. et al. (2012) Rapid evolution and spread of carbapenemases among Enterobacteriaceae in Europe. Clin. Microbiol. Infect. 18, 413–431.
| Rapid evolution and spread of carbapenemases among Enterobacteriaceae in Europe.Crossref | GoogleScholarGoogle Scholar |
[23] Kitchel, B. et al. (2009) Molecular epidemiology of KPC-producing Klebsiella pneumoniae isolates in the United States: clonal expansion of multilocus sequence type 258. Antimicrob. Agents Chemother. 53, 3365–3370.
| Molecular epidemiology of KPC-producing Klebsiella pneumoniae isolates in the United States: clonal expansion of multilocus sequence type 258.Crossref | GoogleScholarGoogle Scholar |
[24] Yong, D. et al. (2009) Characterization of a new metallo-beta-lactamase gene, bla NDM-1, and a novel erythromycin esterase gene carried on a unique genetic structure in Klebsiella pneumoniae sequence type 14 from India. Antimicrob. Agents Chemother. 53, 5046–5054.
| Characterization of a new metallo-beta-lactamase gene, bla NDM-1, and a novel erythromycin esterase gene carried on a unique genetic structure in Klebsiella pneumoniae sequence type 14 from India.Crossref | GoogleScholarGoogle Scholar |
[25] Nordmann, P. (2012) Carbapenem resistance in Enterobacteriaceae: here is the storm! Trends Mol. Med. 18, 263–272.
| Carbapenem resistance in Enterobacteriaceae: here is the storm!Crossref | GoogleScholarGoogle Scholar |
[26] Walsh, T.R. and Toleman, M.A. (2012) The emergence of pan-resistant Gram-negative pathogens merits a rapid global political response. J. Antimicrob. Chemother. 67, 1–3.
| The emergence of pan-resistant Gram-negative pathogens merits a rapid global political response.Crossref | GoogleScholarGoogle Scholar |
[27] Perry, J.D. et al. (2011) Prevalence of faecal carriage of Enterobacteriaceae with NDM-1 carbapenemase at military hospitals in Pakistan, and evaluation of two chromogenic media. J. Antimicrob. Chemother. 66, 2288–2294.
| Prevalence of faecal carriage of Enterobacteriaceae with NDM-1 carbapenemase at military hospitals in Pakistan, and evaluation of two chromogenic media.Crossref | GoogleScholarGoogle Scholar |
[28] Walsh, T.R. et al. (2011) Dissemination of NDM-1 positive bacteria in the New Delhi environment and its implications for human health: an environmental point prevalence study. Lancet Infect. Dis. 11, 355–362.
| Dissemination of NDM-1 positive bacteria in the New Delhi environment and its implications for human health: an environmental point prevalence study.Crossref | GoogleScholarGoogle Scholar |
[29] UK Health Protection Agency http:www.hpa.org.uk/Topics/InfectiousDiseases/InfectionsAZ/CarbapenemResistance/EpidemiologicalData/. accessed 11 November 2012.
[30] Centers for Disease Control and Prevention (2012) Carbapenem-resistant Enterobacteriaceae containing New Delhi metallo-beta-lactamase in two patients – Rhode Island, March 2012. MMWR Morb. Mortal. Wkly. Rep. 61, 446–448.
[31] Sidjabat, H. et al. (2011) Carbapenem resistance in Klebsiella pneumoniae due to the New Delhi Metallo-beta-lactamase. Clin. Infect. Dis. 52, 481–484.
| Carbapenem resistance in Klebsiella pneumoniae due to the New Delhi Metallo-beta-lactamase.Crossref | GoogleScholarGoogle Scholar |
[32] Arpin, C. et al. (2012) NDM-1-producing Klebsiella pneumoniae resistant to colistin in a French community patient without history of foreign travel. Antimicrob. Agents Chemother. 56, 3432–3434.
| NDM-1-producing Klebsiella pneumoniae resistant to colistin in a French community patient without history of foreign travel.Crossref | GoogleScholarGoogle Scholar |
[33] Rimrang, B. et al. (2012) Emergence of NDM-1- and IMP-14a-producing Enterobacteriaceae in Thailand. J. Antimicrob. Chemother. 67, 2626–2630.
| Emergence of NDM-1- and IMP-14a-producing Enterobacteriaceae in Thailand.Crossref | GoogleScholarGoogle Scholar |
[34] Chen, Y. et al. (2011) Emergence of NDM-1-producing Acinetobacter baumannii in China. J. Antimicrob. Chemother. 66, 1255–1259.
| Emergence of NDM-1-producing Acinetobacter baumannii in China.Crossref | GoogleScholarGoogle Scholar |
[35] Wang, Y. et al. (2012) Identification of New Delhi metallo-beta-lactamase 1 in Acinetobacter lwoffii of food animal origin. PLoS ONE 7, e37152.
| Identification of New Delhi metallo-beta-lactamase 1 in Acinetobacter lwoffii of food animal origin.Crossref | GoogleScholarGoogle Scholar |
[36] Peleg, A.Y. et al. (2008) Acinetobacter baumannii: emergence of a successful pathogen. Clin. Microbiol. Rev. 21, 538–582.
| Acinetobacter baumannii: emergence of a successful pathogen.Crossref | GoogleScholarGoogle Scholar |
[37] Higgins, P.G. et al. (2010) Global spread of carbapenem-resistant Acinetobacter baumannii. J. Antimicrob. Chemother. 65, 233–238.
| Global spread of carbapenem-resistant Acinetobacter baumannii.Crossref | GoogleScholarGoogle Scholar |
[38] Post, V. et al. (2010) Evolution of AbaR-type genomic resistance islands in multiply antibiotic-resistant Acinetobacter baumannii. J. Antimicrob. Chemother. 65, 1162–1170.
| Evolution of AbaR-type genomic resistance islands in multiply antibiotic-resistant Acinetobacter baumannii.Crossref | GoogleScholarGoogle Scholar |
[39] Runnegar, N. et al. (2010) Molecular epidemiology of multidrug-resistant Acinetobacter baumannii in a single institution over a 10-year period. J. Clin. Microbiol. 48, 4051–4056.
| Molecular epidemiology of multidrug-resistant Acinetobacter baumannii in a single institution over a 10-year period.Crossref | GoogleScholarGoogle Scholar |
[40] Poirel, L. and Nordmann, P. (2006) Carbapenem resistance in Acinetobacter baumannii: mechanisms and epidemiology. Clin. Microbiol. Infect. 12, 826–836.
| Carbapenem resistance in Acinetobacter baumannii: mechanisms and epidemiology.Crossref | GoogleScholarGoogle Scholar |
[41] Mussi, M.A. et al. (2007) CarO, an Acinetobacter baumannii outer membrane protein involved in carbapenem resistance, is essential for L-ornithine uptake. FEBS Lett. 581, 5573–5578.
| CarO, an Acinetobacter baumannii outer membrane protein involved in carbapenem resistance, is essential for L-ornithine uptake.Crossref | GoogleScholarGoogle Scholar |
[42] Vila, J. et al. (2007) Porins, efflux pumps and multidrug resistance in Acinetobacter baumannii. J. Antimicrob. Chemother. 59, 1210–1215.
| Porins, efflux pumps and multidrug resistance in Acinetobacter baumannii.Crossref | GoogleScholarGoogle Scholar |
[43] Turton, J.F. et al. (2006) Identification of Acinetobacter baumannii by detection of the bla OXA-51-like carbapenemase gene intrinsic to this species. J. Clin. Microbiol. 44, 2974–2976.
| Identification of Acinetobacter baumannii by detection of the bla OXA-51-like carbapenemase gene intrinsic to this species.Crossref | GoogleScholarGoogle Scholar |
[44] Turton, J.F. et al. (2006) The role of ISAba1 in expression of OXA carbapenemase genes in Acinetobacter baumannii. FEMS Microbiol. Lett. 258, 72–77.
| The role of ISAba1 in expression of OXA carbapenemase genes in Acinetobacter baumannii.Crossref | GoogleScholarGoogle Scholar |
[45] Poirel, L. and Nordmann, P. (2006) Genetic structures at the origin of acquisition and expression of the carbapenem-hydrolyzing oxacillinase gene bla OXA-58 in Acinetobacter baumannii. Antimicrob. Agents Chemother. 50, 1442–1448.
| Genetic structures at the origin of acquisition and expression of the carbapenem-hydrolyzing oxacillinase gene bla OXA-58 in Acinetobacter baumannii.Crossref | GoogleScholarGoogle Scholar |
[46] Hamouda, A. et al. (2011) Epidemiology of Acinetobacter baumannii of animal origin. Int. J. Antimicrob. Agents 38, 314–318.
| Epidemiology of Acinetobacter baumannii of animal origin.Crossref | GoogleScholarGoogle Scholar |
